Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Antiretroviral therapy: current drugs.

Pau AK, George JM.

Infect Dis Clin North Am. 2014 Sep;28(3):371-402. doi: 10.1016/j.idc.2014.06.001. Review.

2.

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future.

Harris M, Nosyk B, Harrigan R, Lima VD, Cohen C, Montaner J.

AIDS Res Treat. 2012;2012:595762. doi: 10.1155/2012/595762. Epub 2012 Nov 8.

3.

Effects of tipranavir, darunavir, and ritonavir on platelet function, coagulation, and fibrinolysis in healthy volunteers.

Kort JJ, Aslanyan S, Scherer J, Sabo JP, Kohlbrenner V, Robinson P.

Curr HIV Res. 2011 Jun;9(4):237-46. doi: 10.2174/157016211796320306.

4.

Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors.

Talbot A, Grant P, Taylor J, Baril JG, Liu TF, Charest H, Brenner B, Roger M, Shafer R, Cantin R, Zolopa A.

Antimicrob Agents Chemother. 2010 Jun;54(6):2473-9. doi: 10.1128/AAC.00096-10. Epub 2010 Apr 5.

5.

Metabolism-mediated drug interactions associated with ritonavir-boosted tipranavir in mice.

Li F, Wang L, Guo GL, Ma X.

Drug Metab Dispos. 2010 May;38(5):871-8. doi: 10.1124/dmd.109.030817. Epub 2010 Jan 26.

Supplemental Content

Write to the Help Desk